fax: 39-0250320410
Editorial
You have full text access to this OnlineOpen article
Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option†‡
Article first published online: 30 NOV 2011
DOI: 10.1002/hep.24684
Copyright © 2011 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Sangiovanni, A. and Colombo, M. (2011), Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option. Hepatology, 54: 1898–1900. doi: 10.1002/hep.24684
- †
Potential conflict of interest: Dr. Colombo advises, is on the speakers' bureau of, and received grants from Merck, Bayer, Roche, Bristol-Myers Squibb, and Gilead.
- ‡
See Article on Page 1956
- §
fax: 39-0250320410
Publication History
- Issue published online: 30 NOV 2011
- Article first published online: 30 NOV 2011
- Accepted manuscript online: 19 SEP 2011 09:05AM EST
- Manuscript Accepted: 7 SEP 2011
- Manuscript Received: 1 SEP 2011
- Abstract
- Article
- References
- Cited By
No abstract is available for this article.

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)